ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Artiva Biotherapeutics
The Director, MSAT, CMC & Process Validation will lead end‑to‑end process validation for Artiva's allogeneic NK cell manufacturing, overseeing strategy, execution, and continued process verification from design through PPQ and beyond. This senior role partners across MSAT, CMC, Quality, and GMP manufacturing, providing hands‑on technical leadership, data management, and regulatory support to advance late‑stage development toward commercial readiness.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2019
Artiva Biotherapeutics is a clinical-stage biotechnology company focused on developing natural killer (NK) cell-based therapies for autoimmune diseases. Their lead product candidate, AlloNK®, is a non-genetically modified, cryopreserved NK cell therapy being evaluated in combination with B-cell targeted monoclonal antibodies (mAbs) across multiple clinical trials, including basket trials in rheumatoid arthritis and Sjögren's disease. The company leverages highly scaled, off-the-shelf, allogeneic NK cell manufacturing to make cell therapies broadly accessible to patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Artiva Biotherapeutics.
Right around the average for this role